Lipocine Inc. (LPCN) › Capital ExpendituresLipocine Inc. (LPCN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $12.3K2013: $1.2K2014: $59.6K2015: $28.7K2016: $59.6K2017: $02018: $02021: $7.6K2022: $133.8K2023: $13.2K2024: $90.1K$90.1K2012Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$90.1K+584.2%2023$13.2K-90.2%2022$133.8K+1663.0%2021$7.6K—2018$0—2017$0-100.0%2016$59.6K+107.9%2015$28.7K-51.9%2014$59.6K+4842.6%2013$1.2K-90.2%2012$12.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share